Investegate | Company Announcement
Investegate announcements from Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer
Stay updated with breaking news from Erich Platzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer
Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer Frank Weber, MD, current Chief Medical Officer , promoted to Chief Executive Officer to lead...
Vivoryon Therapeutics N.V. Reports Outcome of 2023 Annual General Meeting All proposed resolutions approvedElection of two new Non-Executive Board...
Vivoryon Therapeutics N.V. Announces CEO Transition Plan Dr. Ulrich Dauer not to extend current term running through 2024 AGMBoard to initiate succession planning Halle /... | June 15, 2023
SAN DIEGO and TORONTO, May 23, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...